American Society for Bone and Mineral Research
Evaluate both fracture, mortality risks to inform osteoporosis treatment for older men
Fracture and mortality risks for men aged 80 years or older have different profiles, and an assessment of both could help to inform osteoporosis drug treatment decisions, according to a speaker.
Proposed FRAX multipliers overestimate fracture risk for women with recent fracture
Variables added to adjust the Fracture Risk Assessment Tool for recent fractures overestimated risk in a cohort of older women from Canada, according to a speaker.
BMD loss seen in early adulthood for women, despite healthy behaviors
A menarche-centered model assessing age at peak bone mineral density suggests bone loss women may begin as soon as 5 years after menarche, even among athletes, according to an analysis of longitudinal data.
VITAL: No fracture risk reduction with supplemental vitamin D
Vitamin D3 supplementation did not reduce fracture risk in a large cohort of U.S. adults not selected for vitamin D deficiency or osteoporosis, according to an ancillary analysis of the VITAL trial.
Exercise builds bone strength during menopause
Postmenopausal women with low bone mass saw greater gains in spine bone mineral density and less bone turnover when assigned monthly risedronate therapy compared with a 12-month regimen of impact and resistance exercises, study data show.
Hip fracture hospitalizations down 11% during first COVID-19 lockdown
Hip fracture hospitalizations decreased by 11% in France during the first COVID-19 lockdown compared with the year before, according to a speaker at the American Society for Bone and Mineral Research Annual Meeting.
Lessons from the pandemic: Embrace ‘open science,’ confront exclusion of investigators
The COVID-19 pandemic brought extensive changes to the biomedical science community and revealed research lessons clinicians and scientists should heed going forward, according to a speaker.